YUBIOLOGICS Signs 13 Billion KRW Cholera Vaccine Contract with UNICEF
[Asia Economy Reporter Hwang Yoon-joo] UbioLogics announced on the 21st that it has signed a supply contract worth 13 billion KRW for oral cholera vaccine (Ubicol-Plus) with UNICEF. This amount corresponds to 45.66% of recent sales revenue. The contract period is from March 18, 2022, to May 25, 2022.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The company stated, "The contract amount is the KRW equivalent of $10,703,133.4 for a quantity of 5,772,300 doses of cholera vaccine."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
